InsidersTradesSigma
Total declarations
Company
▲ Purchases (17 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Titterton Lewis H jr, Director. Director active across 1 companies, notably Anixa Biosciences Inc. In total, 18 disclosures have been recorded. Total volume traded: €682k. The latest transaction was disclosed on 24 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
€73,43130,000 shares@ €2.44770.078% mcap9.7% of flow
Common Stock
SEC:0001493152-22-017926:0·
€26,21310,000 shares@ €2.62130.028% mcap3.5% of flow
Common Stock
SEC:0001493152-22-011291:0·
Ideal exit: 21 Jan 2023 (T+270)
€14,4285,000 shares@ €2.88570.015% mcap4.4% of flow
Common Stock
SEC:0001493152-22-001112·
Ideal exit: 9 Oct 2022 (T+270)
€14,4285,000 shares@ €2.88570.015% mcap1.9% of flow
Common Stock
SEC:0001493152-22-001112:0·
Ideal exit: 9 Oct 2022 (T+270)
€5,6492,000 shares@ €2.82430.0060% mcap1.7% of flow
Common Stock
SEC:0001493152-22-001018·
Ideal exit: 8 Oct 2022 (T+270)
€5,6492,000 shares@ €2.82430.0060% mcap0.7% of flow
Common Stock
SEC:0001493152-22-001018:0·
Ideal exit: 8 Oct 2022 (T+270)
€16,2766,000 shares@ €2.71270.017% mcap5.0% of flow
Common Stock
SEC:0001493152-22-000899·
Ideal exit: 7 Oct 2022 (T+270)
€16,2766,000 shares@ €2.71270.017% mcap2.2% of flow
Common Stock
SEC:0001493152-22-000899:0·
Ideal exit: 7 Oct 2022 (T+270)
€29,99111,000 shares@ €2.72640.032% mcap9.2% of flow
Common Stock
SEC:0001493152-22-000767·
Ideal exit: 4 Oct 2022 (T+270)
€29,99111,000 shares@ €2.72640.032% mcap4.0% of flow
Common Stock
SEC:0001493152-22-000767:0·
Ideal exit: 4 Oct 2022 (T+270)
€74,32818,244 shares@ €4.07410.079% mcap22.7% of flow
Common Stock
SEC:0001493152-21-026841·
Ideal exit: 26 Jul 2022 (T+270)
€74,32818,244 shares@ €4.07410.079% mcap9.8% of flow
Common Stock
SEC:0001493152-21-026841:0·
Ideal exit: 26 Jul 2022 (T+270)
€106,96330,000 shares@ €3.56540.11% mcap32.6% of flow
Common Stock
SEC:0001493152-21-017937·
Ideal exit: 22 Apr 2022 (T+270)
€106,96330,000 shares@ €3.56540.11% mcap14.2% of flow
Common Stock
SEC:0001493152-21-017937:0·
Ideal exit: 22 Apr 2022 (T+270)
€6,7982,200 shares@ €3.09010.0072% mcap2.1% of flow
Common Stock
SEC:0001493152-21-017157·
Ideal exit: 11 Apr 2022 (T+270)
€6,7982,200 shares@ €3.09010.0072% mcap0.9% of flow
Common Stock
SEC:0001493152-21-017157:0·
Ideal exit: 11 Apr 2022 (T+270)
€73,24723,300 shares@ €3.14370.077% mcap22.4% of flow
Common Stock
SEC:0001493152-21-016912·
Ideal exit: 10 Apr 2022 (T+270)
€73,24723,300 shares@ €3.14370.077% mcap9.7% of flow
Common Stock
SEC:0001493152-21-016912:0·
Ideal exit: 10 Apr 2022 (T+270)
18 of 18 declarations
About Titterton Lewis H jr
Titterton Lewis H jr is an executive at Anixa Biosciences Inc.
